Patents Assigned to GOWEY RESEARCH GROUP PLLC
  • Patent number: 11414663
    Abstract: Compositions and methods for treating a disease are described herein. Compositions having plant preparations, microRNAs, and one or more rate limiters are administered to a patient to promote DNA damage repair and modulate endothelial and mitochondrial function, thereby allowing for healing to occur.
    Type: Grant
    Filed: August 17, 2020
    Date of Patent: August 16, 2022
    Assignee: GOWEY RESEARCH GROUP, PLLC
    Inventor: Brandie Gowey
  • Patent number: 11344505
    Abstract: Formulations and methods for treating inflammation using pitcher plants are described herein. The pitcher plant is made into herbal preparations, such as tinctures and infused solutions. The herbal preparation of the pitcher plant can be combined with vitamins, minerals, glutathione, solutions, and other plant preparations, such as a hemp plant preparation containing cannabidiol, to make a topical formulation. Administering the formulation to a subject can reduce and treat inflammation.
    Type: Grant
    Filed: October 5, 2018
    Date of Patent: May 31, 2022
    Assignee: GOWEY RESEARCH GROUP, PLLC
    Inventor: Brandie Gowey
  • Patent number: 10758578
    Abstract: Formulations and methods for treating inflammation using pitcher plants. The pitcher plant is made into herbal preparations, such as tinctures and infused solutions. The herbal preparation of the pitcher plant is combined with glutathione, solutions, supplements, or other plant preparations to make a composition. Administering the composition to a subject can reduce inflammation, increase fibroblast growth factors, and adjust fibrinogen to homeostatic levels, thereby treating the inflammation.
    Type: Grant
    Filed: January 7, 2016
    Date of Patent: September 1, 2020
    Assignee: GOWEY RESEARCH GROUP PLLC
    Inventor: Brandie Gowey
  • Patent number: 10744151
    Abstract: Compositions and methods for treating a disease are described herein. Compositions having plant preparations, microRNAs, and one or more rate limiters are administered to a patient to promote DNA damage repair and modulate endothelial and mitochondrial function, thereby allowing for healing to occur.
    Type: Grant
    Filed: October 5, 2018
    Date of Patent: August 18, 2020
    Assignee: GOWEY RESEARCH GROUP PLLC
    Inventor: Brandie Gowey